Celsion Corporation (CLSN)

[kris_kade]

Agree. I strongly suspect (again, it's my opinion only) that Hisun has a very good idea on the trial outcome from their local contacts. As much as CLSN, they have big stake too in terms of both manufacturing contract as well as selling the Tdox to vast number of HCC patients in China, Hongkong etc.

Hisun could have inked an agreement 4Q 2012 or even earlier but with no certainty on when the results will be announced or 380 will be evented, they could not possibly sign an open-ended contract with CLSN. The 60 day period does exactly opposite - being closer to data release window.

Finally I have seen others pointing out that $5 mill is a chump change for Hisun for taking the risk but I don't buy that argument. Apart from money, they as a premier pharma company in China would look real stupid if the results come out negative days after the deal was signed with a non-refundable deposit.